Monurol
(QZJIMDIBFFHQDW-LMLSDSMGSA-N)
Structure
- SMILES
- [O-]P(=O)([C@H]1O[C@H]1C)O.OCC(CO)(CO)[NH3+]
- Molecular Formula:
- C7H18NO7P
- Molecular Weight:
- 259.194
- Log P:
- -2.7089
- Hydrogen Bond Acceptor:
- 7
- Hydrogen Bond Donor:
- 5
- TPSA:
- 171.03
- CAS Number(s):
- 78964-85-9
Synonym(s)
1.
Monurol
2.
Fosfomycin tromethamine
External Link(s)
| PubChem Compound | 54331 10199068 |
| ChEBI | 5162 |
| CHEMBL | CHEMBL1200331 |
| KEGG | dr:D00925 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Drug ineffective | FAERS: 13 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 2 | Urticaria | FAERS: 5 | US FAERS | |
| 3 | Product use issue | FAERS: 4 | US FAERS | |
| 4 | Urinary tract infection | FAERS: 4 | US FAERS | |
| 5 | Vomiting | FAERS: 3 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 6 | Abdominal Pain | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 7 | Clostridium difficile infection | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 8 | Drug ineffective for unapproved indication | FAERS: 2 | US FAERS | |
| 9 | Headache | FAERS: 2 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 10 | Hypersensitivity | FAERS: 2 | US FAERS | |
| 11 | Impaired driving ability | FAERS: 2 | US FAERS | |
| 12 | Malaise | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 13 | Nausea | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 14 | Product prescribing error | FAERS: 2 | US FAERS | |
| 15 | Syncope | FAERS: 2 | US FAERS | |
| 16 | Vascular purpura | FAERS: 2 | US FAERS | |
| 17 | Abasia | FAERS: 1 | US FAERS | |
| 18 | Abdominal discomfort | FAERS: 1 | US FAERS | |
| 19 | Alanine Aminotransferase Increased | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 20 | Anaphylactic shock | FAERS: 1 | US FAERS | |
| 21 | Arthralgia | FAERS: 1 | US FAERS | |
| 22 | Arthritis | FAERS: 1 | US FAERS | |
| 23 | Aspartate Aminotransferase Increased | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 24 | Asthenia | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 25 | Asthma | FAERS: 1 | US FAERS | |
| 26 | Atrial tachycardia | FAERS: 1 | US FAERS | |
| 27 | Autoimmune hepatitis | FAERS: 1 | US FAERS | |
| 28 | Bladder discomfort | FAERS: 1 | US FAERS | |
| 29 | Bowel movement irregularity | FAERS: 1 | US FAERS | |
| 30 | Cataract | FAERS: 1 | US FAERS | |
| 31 | Clostridium colitis | FAERS: 1 | US FAERS | |
| 32 | Clostridium difficile colitis | FAERS: 1 | US FAERS | |
| 33 | Contraindicated product prescribed | FAERS: 1 | US FAERS | |
| 34 | Drug dose omission | FAERS: 1 | US FAERS | |
| 35 | Drug effect incomplete | FAERS: 1 | US FAERS | |
| 36 | Expired product administered | FAERS: 1 | US FAERS | |
| 37 | Fatigue | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 38 | Gastrointestinal Pain | FAERS: 1 | US FAERS | |
| 39 | Genital burning sensation | FAERS: 1 | US FAERS | |
| 40 | Hallucinations, mixed | FAERS: 1 | US FAERS | |
| 41 | Hepatitis | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 42 | Hypotension | FAERS: 1 | US FAERS | |
| 43 | Inappropriate schedule of product administration | FAERS: 1 | US FAERS | |
| 44 | Incorrect drug administration duration | FAERS: 1 | US FAERS | |
| 45 | Intercepted product prescribing error | FAERS: 1 | US FAERS | |
| 46 | Leukocytoclastic vasculitis | FAERS: 1 | US FAERS | |
| 47 | Lip swelling | FAERS: 1 | US FAERS | |
| 48 | Lymphadenopathy | FAERS: 1 | US FAERS | |
| 49 | Mental impairment | FAERS: 1 | US FAERS | |
| 50 | Neutropenia | FAERS: 1 | US FAERS | |
| 51 | No adverse event | FAERS: 1 | US FAERS | |
| 52 | Optic Neuritis | FAERS: 1 | US FAERS | |
| 53 | Pain | FAERS: 1 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 54 | Poor quality sleep | FAERS: 1 | US FAERS | |
| 55 | Pyelonephritis | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 56 | Sinus Tachycardia | FAERS: 1 | US FAERS | |
| 57 | Therapeutic response unexpected | FAERS: 1 | US FAERS | |
| 58 | Therapy non-responder | FAERS: 1 | US FAERS | |
| 59 | Thrombocytopenic purpura | FAERS: 1 | US FAERS | |
| 60 | Urine output increased | FAERS: 1 | US FAERS | |
| 61 | Vitreous floaters | FAERS: 1 | US FAERS | |
| 62 | Walking aid user | FAERS: 1 | US FAERS | |
| 63 | Weight decreased | FAERS: 1 | US FAERS | |
| 64 | Wrong technique in product usage process | FAERS: 1 | US FAERS | |
| 65 | pseudomembranous colitis | FAERS: 1 | US FAERS | |
| 66 | Ageusia | Canada Vigilance: 1 | Canada Vigilance | |
| 67 | Amnesia | Canada Vigilance: 1 | Canada Vigilance | |
| 68 | Anxiety | Canada Vigilance: 1 | Canada Vigilance | |
| 69 | Back Pain | Canada Vigilance: 1 | Canada Vigilance | |
| 70 | Chills | Canada Vigilance: 1 | Canada Vigilance | |
| 71 | Dizziness | Canada Vigilance: 1 | Canada Vigilance | |
| 72 | Feeling of body temperature change | Canada Vigilance: 1 | Canada Vigilance | |
| 73 | Impaired quality of life | Canada Vigilance: 1 | Canada Vigilance | |
| 74 | Musculoskeletal stiffness | Canada Vigilance: 1 | Canada Vigilance | |
| 75 | Neck Pain | Canada Vigilance: 1 | Canada Vigilance | |
| 76 | Visual Impairment | Canada Vigilance: 1 | Canada Vigilance | |
| 77 | Vulvovaginal pruritus | Canada Vigilance: 1 | Canada Vigilance | |
| 78 | White blood cell count decreased | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.